NUTRIENT OPTIMIZATION FOR HIGH-DENSITY BIOLOGICAL PRODUCTION APPLICATIONS

被引:25
作者
JAYME, DW
机构
[1] GIBCO/Life Technologies, Inc., Grand Island, NY
关键词
HIGH DENSITY; CELL CULTURE; SERUM-FREE MEDIUM; HYBRIDOMA; CHO CELLS; VIRUS PRODUCTION; INSECT CELLS; ADOPTIVE IMMUNOTHERAPY;
D O I
10.1007/BF00365531
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
At the 1989 annual meeting of the U.S. Tissue Culture Associations, Ricahrd am, a leading investigator in the serum-free nutrient requirements of cultured cells, commented on the process of medium development. He noted that a survey of major media manufacturers revealed that, among the top selling mammalian cell culture media formulations, most were nearly thirty years old. This commentary is noteworthy considering the tremendous changes in cell culture understanding and derived applications which have emerged over these three decades. Fastidious cell types relatively unknown to investigators of the 1950s and 1960s are now being cultivated in defined, serum-free environments. Culture environments range from limiting dilution clonal recoveries to maintenance cultures approaching tissue densities. While research applications continue to predominate, applications of cell culture have expanded to the engineered production of biopharmaceuticals, to replacement of animal models for toxicology testing, and to the preservation, activation and expansion of human cells, tissues and organs. It is likely that future nutrient medium development will be predicated upon the design of a minimal number of defined formulations of relatively generic utility to a broad class of cell types. Analytical techniques derived from those described herein will be exploited in the user laboratory and in collaboration with the supplier to optimize the nutrient composition for the desired biological response. © 1991 Kluwer Academic Publishers.
引用
收藏
页码:15 / 30
页数:16
相关论文
共 62 条
[1]  
Barnes D., Serum-free animal cell culture, BioTechniques, 5, pp. 534-542, (1987)
[2]  
Barnes D.W., Sirbasku D.A., Sato G.H., Cell culture methods for molecular and cell biology. Vols. 1–4, (1984)
[3]  
Beckner S.K., Maluish A.E., Longo D.L., Lymphokine-activated killer cells: culture conditions for the generation of maximal in vitro cytotoxicity in cells from normal donors, Canc. Res., 47, pp. 5504-5508, (1987)
[4]  
Boone C.W., Mantel N., Caruso T.D., Kazam E., Stevenson R.E., Quality control studies on fetal bovine serum used in tissue culture, In Vitro, 7, pp. 174-189, (1972)
[5]  
Bottenstein J., Hayashi I., Hutchings S., Masui H., Mather J., McClure D.B., Ohasa S., Rizzino A., Sato G., Serrero G., Wolfe R., Wu R., The growth of cells in serum-free hormone-supplemented media, Meth. Enzymol., 58, pp. 94-109, (1979)
[6]  
Brown B.L., Reducing costs upfront: two methods for adapting hybridoma cells to an inexpensive, chemically-defined serum-free medium, Commercial Production of Monoclonal Antibodies, pp. 35-48, (1987)
[7]  
Clark J.M., Hirtenstein M.D., Optimizing culture conditions for the production of animal cells in microcarrier culture, Ann. NY Acad. Sci. USA, 369, pp. 33-46, (1981)
[8]  
Cohn E.J., Strong L.E., Hughes W.L., Mulford D.J., Ashworth J.N., Melin M., Taylor H.L., Preparation and properties of serum and plasma proteins: a system for the separation into fractions of protein and lipoprotein components of biological tissues and fluids, J. Amer. Chem. Soc., 68, pp. 459-475, (1946)
[9]  
Eagle H., Nutrition needs of mammalian cells in culture, Science, 122, pp. 501-504, (1955)
[10]  
Familletti P.C., Fredericks J.E., Techniques for mammalian cell immobilization, Bio/Technology, 6, pp. 41-44, (1988)